Chao, M., Chang, L., Tu, H., Chang, C., Lai, M., Chen, Y., . . . Pan, S. (2019). Combination treatment strategy for pancreatic cancer involving the novel HDAC inhibitor MPT0E028 with a MEK inhibitor beyond K-Ras status. Clin Epigenetics.

Chao, Min-Wu, Li-Hsun Chang, Huang-Ju Tu, Chao-Di Chang, Mei-Jung Lai, Yi-Ying Chen, Jing-Ping Liou, Che-Ming Teng, and Shiow-Lin Pan. "Combination Treatment Strategy for Pancreatic Cancer Involving the Novel HDAC Inhibitor MPT0E028 With a MEK Inhibitor Beyond K-Ras Status." Clin Epigenetics 2019.

Chao, Min-Wu, et al. "Combination Treatment Strategy for Pancreatic Cancer Involving the Novel HDAC Inhibitor MPT0E028 With a MEK Inhibitor Beyond K-Ras Status." Clin Epigenetics 2019.